Castro, Patricia
Corredor, Germán
Koyuncu, Can
Nordstrom, Luke A.
Tiji, Michelle
Leavitt, Taylor
Lewis, James S. Jr.
Madabhushi, Anant
Frederick, Mitchell J.
Sandulache, Vlad C.
Funding for this research was provided by:
VA CSRD (1IK2CX001953)
Article History
Received: 15 August 2023
Accepted: 24 October 2023
First Online: 23 November 2023
Declarations
:
: The authors declare no competing interests.
: There are no conflicts of interest directly related to this work. Dr. Sandulache is a consultant for Femtovox Inc. Dr. Madabhushi is an equity holder in Picture Health, Elucid Bioimaging, and Inspirata Inc. Currently he serves on the advisory board of Picture Health, Aiforia Inc, and SimBioSys. He also currently consults for Roche, Biohme, and Castle Biosciences. He also has sponsored research agreements with AstraZeneca, Boehringer-Ingelheim, Eli-Lilly and Bristol Myers-Squibb. His technology has been licensed to Picture Health and Elucid Bioimaging. He is also involved in 3 different R01 grants with Inspirata Inc.